| Financial Year |
March 31 2023 |
| Monetary Funds |
203,658,522.82 |
| Held-for-trading Financial Assets |
283,016,215.91 |
| Notes Receivable |
4,142,994.97 |
| Accounts Receivable |
60,811,885.51 |
| Advances to Suppliers |
11,565,544.97 |
| Other Receivables |
1,487,206.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
58,075,788.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
665,691,125.38 |
| Total Current Assets |
1,288,449,284.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,872,709.66 |
| Investment Properties |
-- |
| Fixed Assetes |
194,116,418.38 |
| Under-construction Projects |
44,705,342.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,251,595.85 |
| R&D expenses |
-- |
| Goodwill |
1,913,334.43 |
| Long-Term Deferred and Prepaid Expenses |
458,520.91 |
| Deferred Income Tax Assets |
3,465,164.81 |
| Other Non-Current Assets |
184,238,013.53 |
| Sub-Total of Non-Current Assets |
490,712,473.25 |
| Total Assets |
1,779,161,758.20 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
24,614,006.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,921,431.52 |
| Taxes Payable |
5,904,303.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,694,311.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,073,204.98 |
| Other Current Liabilities |
795,827.92 |
| Sub-Total of Current Liabilities |
49,841,297.62 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,681,365.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,700,954.18 |
| Total Liabilities |
62,542,251.80 |
| Paid-In Capital(Or Share Stock) |
175,663,412.00 |
| Capital Surplus |
1,197,486,588.93 |
| Surplus Reserve |
39,324,296.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
304,145,209.01 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,716,619,506.40 |
| Owner's Equity（Stockholder's Equity） |
1,716,619,506.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,779,161,758.20 |
